APR Applied Research is a Finalist in Rare Disease International Film Festival
21 Nov 2022 //
PRNEWSWIRE
APR Applied Pharma Signs Agreement To Acquire Rights for New Dosage Form for PKU
15 Mar 2022 //
ACCESSWIRE
Relief Therapeutics` Wholly Owned Subsidiary, APR Applied Pharma Research
27 Oct 2021 //
YAHOO
Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn AOS
20 Oct 2021 //
BIOSPACE
APR Applied Pharma Research, Launches PKU GOLIKE KRUNCH in Germany and Italy
09 Sep 2021 //
BIOSPACE
Relief and APR Applied Pharma Research Sign and Close Definitive Agreement
29 Jun 2021 //
PHARMIWEB
Relief and APR Applied Pharma Research Sign and Close Definitive Agreement
29 Jun 2021 //
BIOSPACE
FDA Grants Orphan Drug Designation to APR-OD031 for the Treatment of (PKU)
26 Mar 2020 //
PRNEWSWIRE